Advertisement
Canada markets close in 4 hours 7 minutes
  • S&P/TSX

    22,363.19
    -12.64 (-0.06%)
     
  • S&P 500

    5,215.37
    +1.29 (+0.02%)
     
  • DOW

    39,441.39
    +53.63 (+0.14%)
     
  • CAD/USD

    0.7318
    +0.0007 (+0.09%)
     
  • CRUDE OIL

    79.11
    -0.15 (-0.19%)
     
  • Bitcoin CAD

    83,176.59
    -1,522.90 (-1.80%)
     
  • CMC Crypto 200

    1,302.78
    -55.23 (-4.17%)
     
  • GOLD FUTURES

    2,371.80
    +31.50 (+1.35%)
     
  • RUSSELL 2000

    2,058.41
    -15.22 (-0.73%)
     
  • 10-Yr Bond

    4.4960
    +0.0470 (+1.06%)
     
  • NASDAQ

    16,318.13
    -28.14 (-0.17%)
     
  • VOLATILITY

    12.81
    +0.12 (+0.95%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6791
    +0.0013 (+0.19%)
     

Atomera Provides First Quarter 2024 Results

LOS GATOS, CA / ACCESSWIRE / April 25, 2024 ­­/ Atomera Incorporated (NASDAQ:ATOM), a semiconductor materials and technology licensing company, today provided a corporate update and announced financial results for the first quarter ended March 31, 2024.

Recent Company Highlights

  • Strong progress with customers in all four market focus segments

  • Record number of commercial proposals in the last three months

  • Promising GaN results in a new product category, Compound Semiconductors

Management Commentary

"As our first commercial customer continues on the path to production, we have been more active on license agreements with other customers than at any time in our history," said Scott Bibaud, President and CEO. "We believe this proposal activity, combined with our potential to enter the compound semiconductor market segment will provide sustaining growth on top of a solid foundation to build Atomera into a premier leader in the semiconductor industry."

ADVERTISEMENT

Financial Results

The Company incurred a net loss of ($4.8) million, or ($0.19) per basic and diluted share in the first quarter of 2024, compared to a net loss of ($5.0) million, or ($0.21) per basic and diluted share, for the first quarter of 2023. Adjusted EBITDA (a non-GAAP financial measure) in the first quarter of 2024 was a loss of ($4.0) million compared to an adjusted EBITDA loss of ($4.2) million in the first quarter of 2023.

The Company had $19.3 million in cash, cash equivalents and short-term investments as of March 31, 2024, compared to $19.5 million as of December 31, 2023.

The total number of shares outstanding was 26.9 million as of March 31, 2024.

First Quarter 2024 Results Webinar

Atomera will host a live video webinar today to discuss its financial results and recent progress.
Date: Thursday, April 25, 2024
Time: 2:00 p.m. PT (5:00 p.m. ET)
Webcast: Accessible at https://ir.atomera.com

Note about Non­-GAAP Financial Measures
In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a non-GAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, depreciation, amortization and stock-based compensation. Our definition of adjusted EBITDA may not be comparable to the definitions of similarly-titled measures used by other companies. We believe that this non-GAAP financial measure, viewed in addition to and not in lieu of our reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

About Atomera Incorporated
Atomera Incorporated is a semiconductor materials and technology licensing company focused on deploying its proprietary, silicon-proven technology into the semiconductor industry. Atomera has developed Mears Silicon Technology™ (MST®), which increases performance and power efficiency in semiconductor transistors. MST can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nano-scaling technologies already in the semiconductor industry roadmap. More information can be found at www.atomera.com.

Safe Harbor
This press release contains forward-looking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST technology to significantly improve semiconductor performance. Those forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that, to date, we have only recognized minimal engineering services and licensing revenues and we have not yet commenced principal revenue producing operations, thus subjecting us to all of the risks inherent in an early-stage enterprise; (2) the risk that STMicroelectronics does not proceed with qualification of MST in its manufacturing process or does not take MST-enabled products to market, (3) risks related to our ability to successfully complete the milestones in our joint development agreements or, even if successfully completed, to reach a commercial distribution license with our JDA customers; (4) risks related to our ability to advance licensing arrangements with our integration licensees to royalty-based manufacturing and distribution licenses or our ability to add other licensees; (5) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST technology; (6) our ability to protect our proprietary technology, trade secrets and know­how and (7) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K filed with the SEC on February 15, 2024. We caution readers not to place undue reliance on any forward-looking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

-- Financial Tables Follow -

Atomera Incorporated
Condensed Balance Sheets
(in thousands, except per share data)


March 31,

December 31,


2024

2023


(Unaudited)


ASSETS






Current assets:



Cash and cash equivalents

$

14,806

$

12,591

Short-term investments

4,458

6,940

Unbilled contracts receivable

-

550

Interest receivable

73

79

Prepaid expenses and other current assets

328

244

Total current assets

19,665

20,404


Property and equipment, net

83

100

Long-term prepaid maintenance and supplies

91

91

Security deposit

14

14

Operating lease right-of-use asset

459

517

Financing lease right-of-use-asset

2,622

2,903


Total assets

$

22,934

$

24,029


LIABILITIES AND STOCKHOLDERS' EQUITY


Current liabilities:

Accounts payable

$

601

$

618

Accrued expenses

210

222

Accrued payroll related expenses

454

1,382

Current operating lease liability

263

264

Current financing lease liability

1,357

1,328

Deferred revenue

17

-

Total current liabilities

2,902

3,814


Long-term operating lease liability

194

295

Long-term financing lease liability

1,431

1,750


Total liabilities

4,527

5,859


Commitments and contingencies

-

-


Stockholders' equity:

Preferred stock $0.001 par value, authorized 2,500 shares; none issued and outstanding as of March 31 2024 and December 31, 2023

-

-

Common stock: $0.001 par value, authorized 47,500 shares; 26,905 shares issued and 26,885 outstanding as of March 31, 2024; and 26,107 shares issued and outstanding as of December 31, 2023

27

26

Additional paid in capital

226,288

221,229

Other comprehensive income (loss)

(1

)

-

Accumulated deficit

(207,907

)

(203,085

)

Total stockholders' equity

18,407

18,170

Total liabilities and stockholders' equity

$

22,934

$

24,029

Atomera Incorporated
Condensed Statements of Operations
(in thousands, except per share data)
(Unaudited)

Three Months Ended

March 31,

December 31,

March 31,

2024

2023

2023

Revenue

$

18

$

550

$

-

Cost of revenue

(33

)

(28

)

-

Gross margin (loss)

(15

)

522

-

Operating expenses

Research and development

2,858

2,992

3,036

General and administrative

1,811

1,875

1,742

Selling and marketing

350

452

389

Total operating expenses

5,019

5,319

5,167

Loss from operations

(5,034

)

(4,797

)

(5,167

)

Other income (expense)

Interest income

205

195

199

Accretion income

46

62

2

Other income (expense), net

-

3

-

Interest expenses

(39

)

(43

)

(53

)

Total other income (expense), net

212

217

148

)

Net loss

$

(4,822

)

$

(4,580

)

$

(5,019

)

Net loss per common share, basic and diluted

$

(0.19

)

$

(0.18

)

$

(0.21

)

Weighted average number of common shares outstanding, basic and diluted

26,038

25,404

23,660

Atomera Incorporated
Reconciliation to Non-GAAP EBITDA
(Unaudited)

Three Months Ended

March 31,

December 31,

March 31,

2024

2023

2023

Net loss (GAAP)

$

(4,822

)

$

(4,580

)

$

(5,019

)

Depreciation and amortization

17

17

20

Stock-based compensation

1,024

1,015

927

Interest income

(205

)

(195

)

(199

)

Accretion income

(46

)

(62

)

(2

)

Other (income) expense, net

-

(3

)

-

Interest expense

39

43

53

Net loss non-GAAP EBITDA

$

(3,993

)

$

(3,765

)

$

(4,220

)

Investor Contact:
Bishop IR
Mike Bishop
(415) 894-9633
investor@atomera.com

SOURCE: Atomera, Inc



View the original press release on accesswire.com